In a report released today, Justin Walsh from JonesTrading reiterated a Buy rating on Plus Therapeutics (PSTV – Research Report), with a ...

Analyst Divya Gangahar from Morgan Stanley maintained a Buy rating on Grab (GRAB – Research Report) and increased the price target to ...

These stocks are trading at attractive valuations relative to their history, especially in light of their opportunities in ...

Here are seven undervalued stocks to buy, according to CFRA, with forward earnings multiples of less than 15: *As of Sept. 25 ...

Nvidia Corporation's stock faces volatility despite earnings growth. We examine support levels to watch and telltale signs to ...

As usual, Nvidia stock is climbing in 2024, earning 136.3% year-to-date gains for shareholders, although shares have lost ...

Toll Brothers (TOL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the ...

This is not a “set it and forget it” scheme. You want these stocks on your watchlist so that when you find a buy rating or a good time to make your move, you can invest appropriately.

DRChoksey FinServ has recommended six stocks to buy this month which it projects to have the upside potential of up to 28%.

Read here for an update on Tesla's upcoming catalysts in Oct., including the robotaxi event and Q3 release, and TSLA's ...

Shares of chipmaker Advanced Micro Devices (AMD) are trading lower at the time of writing, even though Citi Research kept its Buy rating on AMD after a 15% rise in August notebook shipments.

Pfizer (PFE) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of ...